Reduction of hERG potassium currents by hyperosmolar solutions

Prior research has shown that hERG potassium channels play a key role in cardiac repolarization and are sensitive to various modulators. However, the impact of osmotic changes on these channels remains unclear. Established knowledge includes the use of E-4031 as a selective hERG blocker. That uncertainty drives the need to distinguish drug effects from osmolarity changes. No prior work had resolved how hyperosmolar conditions affect hERG function independently of drug action. This gap motivated the current investigation into whether osmotic stress alone alters hERG currents. The study aims to clarify whether observed effects are due to the drug or the osmotic environment. Understanding this distinction is essential for interpreting drug effects in osmotic conditions.

This study aimed to assess how hyperosmolar solutions affect hERG potassium currents in CHO cells. The specific problem is the potential confounding effect of osmolarity on drug testing. The motivation comes from the need to differentiate drug effects from osmotic effects. The researchers propose that osmolarity changes may mimic or obscure drug actions on hERG channels. The study tests whether hyperosmolarity alone can reduce hERG currents. The goal is to determine if osmotic stress alters current amplitude independently of drug action. This investigation is critical for accurate drug evaluation in hyperosmolar formulations. The findings may guide future studies in osmolarity-controlled experiments.

The study used CHO cells expressing hERG channels to examine the impact of osmotic changes. Researchers added d-mannitol to the external solution to induce hyperosmolarity. Cell shrinkage was observed as a direct effect of osmotic stress. Current amplitude was measured using patch-clamp techniques. The solution's osmolarity was adjusted to specific concentrations. Two concentrations of mannitol were tested: 108 mM and 308 mM. Current-voltage relations were analyzed to detect functional changes. The effects were compared to those of E-4031, a known hERG blocker.

Exposure to 108 mM mannitol reduced hERG current amplitude by 57+/-13%. This effect was partially reversible after removing the hyperosmolar solution. At 308 mM, the current was reduced by 89+/-5%, matching E-4031's blocking effect. Current-voltage relations remained largely unchanged despite amplitude reductions. The osmotic effect was significant but did not alter the voltage dependence of the currents. The magnitude of the reduction at 308 mM suggests a strong osmotic influence. The similarity to E-4031 indicates that osmolarity can mimic drug effects. These findings highlight the importance of osmolarity controls in drug testing.

The authors propose that hyperosmolar solutions can reduce hERG currents independently of drug action. This effect is comparable to that of a selective hERG blocker. The study suggests that osmolarity changes should be controlled in drug experiments. The findings imply that osmotic stress may confound drug effect interpretations. The authors conclude that osmolarity controls are necessary for accurate drug testing. The study does not claim that osmolarity is the only factor affecting hERG function. The results suggest that osmotic effects should be considered in drug formulation studies. The authors do not assert that all drug effects are osmolarity-dependent.